IOVANCE BIOTHERAPEUTICS, INC. Convertible Notes Payable, Current
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Convertible Notes Payable, Current of $0 as of 2013-12-31, per its 10-K filed 2014-03-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleNotesPayableCurrent · last filed 2014-03-28
- 2013-12-31: Convertible Notes Payable, Current $0.00.
- 2013-03-31: Convertible Notes Payable, Current $5.00M.
- 2012-12-31: Convertible Notes Payable, Current $5.00M.
- 2012-09-30: Convertible Notes Payable, Current $5.00M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-28 |
| 2013-03-31 | $5.00M 10-Q · filed 2013-10-23 |
| 2012-12-31 | $5.00M 10-K · filed 2014-03-28 |
| 2012-09-30 | $5.00M 10-Q · filed 2013-01-25 |
| 2012-06-30 | $5.00M 10-Q/A · filed 2012-09-10 |
| 2012-03-31 | $5.00M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $5.00M 10-K · filed 2013-09-23 |
| 2011-09-30 | $2.60M 10-Q · filed 2011-11-21 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |